.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
Western Cannabis concentrated its October 2026 sales in Concentrates at 51.40% share and Pre-Roll at 47.85% share, with Vapor Pens a marginal 0.75%. Year over year, Concentrates declined 55.93% while Pre-Roll fell 71.51%, and month over month the same categories dropped 30.50% and 13.59% respectively, indicating a sharper pullback in Concentrates than in Pre-Roll. Vapor Pens contracted 97.80% year over year but rose 50.55% month over month from a small base, suggesting tentative re-entry rather than material recovery. With average price down 43.43% year over year to $15.29 and Concentrates’ average price at 28.66 versus Pre-Roll at 10.13, mix is tilting toward lower-price units even as premium-priced Concentrates still dominate share, implying price compression is not yet unlocking volume where declines are steepest.
The mix shift and divergent decline rates imply Western Cannabis is overexposed to a high-velocity downtrend in Concentrates while relying on Pre-Roll for steadier, albeit shrinking, volume. Holding 51.40% in Concentrates alongside a 30.50% month-over-month drop and a category rank of 9 in Concentrates in Saskatchewan points to mid-pack visibility that risks further slippage if share migrates to lower-priced Pre-Roll, which fell a lesser 13.59% month over month. The 50.55% month-over-month uptick in Vapor Pens against a 97.80% year-over-year collapse suggests a low-cost test-and-learn lane rather than a growth engine, so maintaining rank 9 while rebalancing toward categories with comparatively smaller month-over-month declines could stabilize positioning without overcommitting to a volatile niche.
Competitive Landscape
Western Cannabis sits at rank #31 in AB Concentrates in October 2026, sliding 13 positions year over year from #18 and falling 21 spots from #10 three months ago, a reversal from its peak at #5 in February 2026; meanwhile, category leaders moved in divergent directions, with BoxHot holding #1 despite a -19.6% year-over-year sales change while Dab Bods rose to #3 on a 72.0% year-over-year increase, indicating Western Cannabis’s rank decline is driven more by relative momentum loss than absolute category contraction and implying continued share pressure if its trajectory does not stabilize.
Notable Products
Western Cannabis is concentrated in a handful of items: the top 10 products account for 75.0% of October 2026 sales, led by Orange Creamsicle Pre-Roll 12-Pack (6g) at 18.9%. That concentration means most of its sales ride on a small core lineup.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
